Welltower (HCN) Raised to “Buy” at ValuEngine
ValuEngine upgraded shares of Welltower (NYSE:HCN) from a hold rating to a buy rating in a research report released on Saturday.
A number of other brokerages have also recently issued reports on HCN. Stifel Nicolaus lowered their target price on Welltower from $75.00 to $74.00 and set a buy rating for the company in a report on Friday, November 3rd. Capital One Financial raised Welltower from an equal weight rating to an overweight rating in a report on Wednesday, November 8th. KeyCorp reaffirmed a hold rating on shares of Welltower in a report on Tuesday, October 17th. Royal Bank of Canada reaffirmed a hold rating and issued a $74.00 target price on shares of Welltower in a report on Tuesday, October 10th. Finally, Stephens set a $70.00 target price on Welltower and gave the stock a buy rating in a report on Friday. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company’s stock. Welltower currently has an average rating of Hold and a consensus price target of $72.92.
Shares of Welltower (HCN) traded down $1.01 during mid-day trading on Friday, hitting $59.16. The company had a trading volume of 2,685,279 shares, compared to its average volume of 1,955,664. Welltower has a twelve month low of $58.98 and a twelve month high of $78.17. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.79. The company has a market cap of $21,910.32, a P/E ratio of 23.85, a P/E/G ratio of 3.92 and a beta of 0.25.
In related news, Director Gary Whitelaw purchased 1,420 shares of the firm’s stock in a transaction dated Tuesday, November 21st. The stock was bought at an average price of $68.39 per share, with a total value of $97,113.80. Following the completion of the purchase, the director now owns 1,420 shares in the company, valued at approximately $97,113.80. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.19% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Spectrum Management Group Inc. acquired a new stake in shares of Welltower in the third quarter valued at about $100,000. Wealthcare Advisory Partners LLC acquired a new stake in shares of Welltower in the third quarter valued at about $101,000. San Francisco Sentry Investment Group CA increased its stake in shares of Welltower by 1,048.5% in the third quarter. San Francisco Sentry Investment Group CA now owns 1,539 shares of the real estate investment trust’s stock valued at $108,000 after buying an additional 1,405 shares during the period. Hudock Capital Group LLC increased its stake in shares of Welltower by 543.7% in the third quarter. Hudock Capital Group LLC now owns 2,002 shares of the real estate investment trust’s stock valued at $140,000 after buying an additional 1,691 shares during the period. Finally, Miles Capital Inc. acquired a new stake in shares of Welltower in the second quarter valued at about $205,000. 86.35% of the stock is owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.dailypolitical.com/2018/01/14/welltower-hcn-raised-to-buy-at-valuengine.html.
Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.